Current Assets
Restricted Cash
Boston Scientific Restricted Cash decreased by 27.6% to $71.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.1%, from $103.00M to $71.00M. Over 4 years (FY 2020 to FY 2024), Restricted Cash shows a downward trend with a -14.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase may signal higher debt service requirements or increased collateral obligations, while a decrease may indicate the release of restricted funds.
Detailed definition
Cash balances that are legally or contractually set aside for specific purposes, such as debt service reserves, collater...
Peer comparison
Common in capital-intensive industries like energy where project financing requires specific reserve accounts.
Metric ID:
restricted_cashHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $167.00M | $155.00M | $188.00M | $146.00M | $132.00M | $112.00M | $149.00M | $135.00M | $135.00M | $123.00M | $130.00M | $93.00M | $75.00M | $70.00M | $111.00M | $103.00M | $109.00M | $98.00M | $71.00M |
| QoQ Change | — | -7.2% | +21.3% | -22.3% | -9.6% | -15.2% | +33.0% | -9.4% | +0.0% | -8.9% | +5.7% | -28.5% | -19.4% | -6.7% | +58.6% | -7.2% | +5.8% | -10.1% | -27.6% |
| YoY Change | — | — | — | — | -21.0% | -27.7% | -20.7% | -7.5% | +2.3% | +9.8% | -12.8% | -31.1% | -44.4% | -43.1% | -14.6% | +10.8% | +45.3% | +40.0% | -31.1% |
Range$70.00M – $188.00M
CAGR-17.3%
Avg YoY Growth-9.7%
Median YoY Growth-14.6%
Current Streak2 quarters decline
Restricted Cash at Other Companies
Frequently Asked Questions
- What is Boston Scientific's restricted cash?
- Boston Scientific (BSX) reported restricted cash of $71.00M in Q1 2026.
- How has Boston Scientific's restricted cash changed year-over-year?
- Boston Scientific's restricted cash decreased by 31.1% year-over-year, from $103.00M to $71.00M.
- What is the long-term trend for Boston Scientific's restricted cash?
- Over 4 years (2020 to 2024), Boston Scientific's restricted cash has grown at a -14.5% compound annual growth rate (CAGR), from $208.00M to $111.00M.
- What does restricted cash mean?
- Cash that is legally tied up and cannot be used for day-to-day operations.